Global Oligonucleotide Synthesis Market Size By Type (Synthesized Oligonucleotides, Reagents), By Application (PCR, DNA), By Region, And Segment Forecasts, 2023 to 2032

The Global Oligonucleotide Synthesis Market was valued at USD 7.6 billion in 2023 and is projected to reach USD 17.4 billion by 2031, growing at a CAGR of 10.8% during the forecast period from 2023 to 2031. Oligonucleotide synthesis plays a crucial role in molecular biology, diagnostics, therapeutics, and research applications. The growth of the market is fueled by increasing demand for custom oligonucleotides, rapid adoption of synthetic DNA and RNA in therapeutic development, and advancements in genomic technologies. The expanding use of oligonucleotides in gene editing, PCR, and next-generation sequencing (NGS) also supports strong market momentum.

Drivers:

1. Rise in Genomic Research and Personalized Medicine: The boom in genomics research, particularly in personalized and precision medicine, is driving the demand for high-quality, custom-synthesized oligonucleotides. These molecules are essential in diagnostic tests, drug development, and gene therapies.

2. Growing Application in Therapeutics: Oligonucleotides are increasingly used in antisense therapy, RNA interference (RNAi), and CRISPR technologies. Their use in treating genetic disorders, cancers, and viral infections is boosting the market significantly.

3. Advancements in Synthesis Technologies: Automated, high-throughput, and error-minimized oligonucleotide synthesizers have improved production scalability and quality. These innovations are reducing costs and making synthesis more accessible to biotech and academic labs.

Restraints:

1. Complex Regulatory Landscape: Oligonucleotide-based therapeutics face stringent regulatory approvals and clinical trial protocols, which can delay product launches and impact market timelines.

2. High Cost of Therapeutic Development: Despite falling synthesis costs, the development and commercialization of oligonucleotide drugs remain expensive, limiting access for smaller firms and developing nations.

Opportunity:

1. Emerging Use in Synthetic Biology and CRISPR Applications: The expanding field of synthetic biology and gene editing technologies like CRISPR-Cas9 is creating new avenues for oligonucleotide synthesis. These applications are revolutionizing gene function analysis and therapeutic development.

2. Expansion into Emerging Economies: Countries in Asia-Pacific and Latin America are witnessing rising investments in healthcare and biotechnology, providing growth opportunities for oligonucleotide service providers and manufacturers.

Market by System Type Insights:

The Custom Oligonucleotides segment held the largest share in 2023, driven by its extensive application in diagnostics, therapeutics, and research. These oligos are tailored for specific gene targets, enabling precision in molecular workflows. Meanwhile, the Pre-designed Oligonucleotides segment is projected to witness the fastest growth owing to their growing use in standard lab assays, gene expression studies, and academic research.

Market by End-use Insights:

The Pharmaceutical & Biotechnology Companies segment dominated the market in 2023, owing to the rising use of oligonucleotides in drug discovery and development. These companies are heavily investing in oligonucleotide therapeutics, particularly for rare diseases and oncology. The Academic Research Institutes segment is also gaining traction due to increasing public funding and collaborations in genomics research.

Market by Regional Insights:

North America led the global oligonucleotide synthesis market in 2023, supported by strong research infrastructure, high adoption of gene therapies, and the presence of major industry players. Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by advancements in biotech research in China and India, growing clinical trial activities, and government initiatives to support genomics and personalized medicine.

Competitive Scenario:

Leading players in the Global Oligonucleotide Synthesis Market include:

Thermo Fisher Scientific Inc.

Integrated DNA Technologies, Inc. (IDT)

Eurofins Genomics

Merck KGaA

GenScript Biotech Corporation

Agilent Technologies, Inc.

LGC Biosearch Technologies

Bio-Synthesis, Inc.

Biolytic Lab Performance Inc.

Biolegio B.V.

These companies are focusing on strategic collaborations, innovation in synthesis platforms, and expansion of manufacturing capabilities. For instance:

In 2024, Thermo Fisher launched an upgraded high-throughput oligo synthesis system for rapid RNA synthesis to support mRNA-based therapeutics.

IDT expanded its manufacturing facility in Belgium in 2023 to meet increasing European demand for custom DNA/RNA oligos.

Eurofins Genomics introduced a next-gen automated synthesis platform to reduce turnaround times and enhance purity levels.

Scope of Work – Global Oligonucleotide Synthesis Market

Report Metric Details

Market Size (2023) USD 7.6 billion

Projected Market Size (2031) USD 17.4 billion

CAGR (2023–2031) 10.8%

Market Segments By System Type (Custom, Pre-designed), By End-use, By Region

Growth Drivers Genomic research boom, therapeutic expansion, synthesis technology

Opportunities CRISPR adoption, biotech investments in emerging economies

Key Market Developments:

March 2024: Merck KGaA collaborated with a biotech startup to enhance LNP (lipid nanoparticle) delivery for oligonucleotide-based drugs.

January 2024: Agilent Technologies introduced a new oligonucleotide purification service aimed at increasing yield and stability for RNA-based therapeutics.

October 2023: GenScript opened a new facility in California to expand its presence in the U.S. custom gene synthesis market.

FAQs:

1) What is the current market size of the Global Oligonucleotide Synthesis Market?

The market was valued at USD 7.6 billion in 2023.

2) What is the major growth driver of the Global Oligonucleotide Synthesis Market?

The key driver is the increasing demand for oligonucleotides in genomics research, therapeutics, and synthetic biology applications.

3) Which is the largest region during the forecast period in the Global Oligonucleotide Synthesis Market?

North America accounted for the largest market share in 2023.

4) Which segment accounted for the largest market share in the Global Oligonucleotide Synthesis Market?

The Custom Oligonucleotides segment held the largest share in 2023.

5) Who are the key market players in the Global Oligonucleotide Synthesis Market?

Key players include Thermo Fisher Scientific, IDT, Eurofins Genomics, Merck KGaA, and GenScript Biotech Corporation.